Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29611600

CN(C)C(=O)Oc1cccc2cccnc12.Cl

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 2/20 0.60
HDAC6 known ✓ Q9UBN7 1/20 0.58
HSP90AA1 known ✓ P07900 1/20 0.58
BCHE known ✓ P06276 2/20 0.51
ACHE known ✓ P22303 1/20 0.49
LMNA P02545 4/20 0.71
L3MBTL1 Q9Y468 4/20 0.71
KDM4E B2RXH2 5/20 0.60
METAP2 P50579 1/20 0.58
METAP1 P53582 1/20 0.58
POLB P06746 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
ALOX15 P16050 1/20 0.56
USP2 O75604 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10385035 0.98 LMNA (0.72) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL9101160 0.84 LMNA (0.66) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL1699754 0.84 KDM4E (0.59) LMNAL3MBTL1KDM4EGAABCHE
Hydrochloric Acid SCHEMBL2563239 0.83 LMNA (0.63) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL10424862 0.82 L3MBTL1 (0.63) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL7364217 0.81 L3MBTL1 (0.62) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL1709119 0.81 NCEH1 (0.62) LMNAL3MBTL1KDM4EGAABCHE
SCHEMBL250301 0.81 LMNA (0.65) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL28459061 0.80 LMNA (0.69) LMNAL3MBTL1KDM4EGAAMETAP2
SCHEMBL795857 0.80 HSP90AA1 (0.68) LMNAL3MBTL1KDM4EGAAMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 EP claimed
US-12522624-B2 Electroluminescent material and device thereof Beijing Summer Sprout Technology Co., Ltd. (CN) 2026-01-13 US claimed
WO-2024121084-A1 PREPARATION OF NITRILES MERCK PATENT GMBH (DE) 2024-06-13 WO claimed
CN-114974630-B Molten salt reactor power measurement method and system 中国科学院上海应用物理研究所 2024-05-10 CN claimed
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 US claimed
CN-115806563-A B-N-containing organic electroluminescent material and application thereof in electroluminescent device 广东阿格蕾雅光电材料有限公司 2023-03-17 CN claimed
WO-2023035820-A1 B-N-CONTAINING ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF IN ELECTROLUMINESCENT DEVICE 广东阿格蕾雅光电材料有限公司 2023-03-16 WO claimed
US-20220274998-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-09-01 US claimed
CN-114974630-A Method and system for measuring power of molten salt reactor 中国科学院上海应用物理研究所 2022-08-30 CN claimed
US-20220231232-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-07-21 US claimed
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-06-09 US claimed
EP-4736603-A1 DICYANOARYL COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2026-05-06 EP disclosed
EP-4078692-B1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2026-03-18 EP disclosed
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 EP disclosed
EP-3658541-B1 SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2025-11-26 EP disclosed
EP-3679024-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-02 EP disclosed
EP-3679023-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-02 EP disclosed
CN-114974630-A Method and system for measuring power of molten salt reactor 中国科学院上海应用物理研究所 2022-08-30 CN disclosed
WO-2022129116-A1 INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS MERCK PATENT GMBH (DE) 2022-06-23 WO disclosed
WO-2022122682-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274998-A1 ELECTROLUMINESCENT DEVICE H1-2, H1-0, L1CAM GAA 1796/4885HDAC6 1554/4885HSP90AA1 2970/4885
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF IDO1, AZI2, YTHDF2 GAA 3688/4885HDAC6 522/4885HSP90AA1 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.